Go Back   Matt-Hughes.com Official Forums > MMA Related > UFC

Thread Tools Display Modes
Old 03-16-2014, 12:37 PM
VCURamFan's Avatar
VCURamFan VCURamFan is offline
Waiting for June 6th
Join Date: Jan 2009
Location: Basketball Capital of the World
Posts: 14,334
Default Dennis Siver tests positive for banned substance following UFC 168

By MMAFighting.com (by Ariel Helwani on Mar 15 2014, 3:32p 25):
Almost three months later, the UFC 168 drug test results are finally in, and they contain one positive result.

UFC featherweight Dennis Siver tested positive for the banned substance human chorionic gonadotropin (hCG) following his unanimous decision win over Manny Gamburyan on Dec. 28, Nevada Athletic Chairman Francisco Aguilar informed MMAFighting.com on Saturday.

"The Nevada Attorney General's office is preparing the appropriate complaint for the State of the Nevada," Aguilar said. He didn't reveal Siver's exact hCG level or what kind of punishment he might receive.

Most commonly known as a female fertility drug, hCG is typically used by steroid users in an effort to restart their testosterone production following steroid usage.

The UFC 168 drug tests results were delayed because both Siver and Siyar Bahadurzada's "A" samples came back inconclusive. As a result, both of their "B" samples were tested and only Siver's came back positive. The other 21 fighters on the card passed their drug tests.

MMAFighting.com contacted Siver two weeks ago for a comment on his inconclusive test, but the German fighter did not respond.

Former MLB star Manny Ramirez most famously tested positive for hCG in 2009 and was subsequently suspended for 50 games. For more on hCG's presence in sports, click here.
Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

All times are GMT. The time now is 02:13 AM.

Powered by vBulletin® Version 3.8.4
Copyright ©2000 - 2017, Jelsoft Enterprises Ltd.